F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review, review of hospital discharge orders, staff interview and review of medication
information from Medscape, the facility failed to ensure a resident received anticoagulant medications as
physician ordered resulting in significant medication errors. This affected one (#10) of three residents
reviewed for medication administration. Facility census was 65.
Residents Affected - Few
Findings include:
Review of medical record for Resident #10 revealed admission date of 10/30/23. Diagnoses include
atherosclerosis of native arteries of extremities with intermittent claudication in bilateral legs, peripheral
vascular disease (PVD), chronic obstructive pulmonary disease (COPD) and diabetes mellitus (DM).
Resident #10 was discharged on 11/02/23 to the emergency room, and then discharged home.
Review of Resident #10's five-day Minimum Data Set (MDS) dated [DATE] revealed the resident had a Brief
Interview Mental Status (BIMS) score of 13 out of 15 indicating intact cognition. He was independent for
eating, bed mobility, clean up assistance for toileting, partial to moderate assistance for transfers.
Review of the hospital admitting orders revealed an order for Enoxaparin Sodium (anticoagulant) inject 0.7
milliliters (ml) under the skin every 12 hours. Warfarin (anticoagulant) five mg tablet, take one and a half
tablets on Monday, Wednesday and Friday. Warfarin five mg tablet, take one tablet on Sunday, Tuesday,
Thursday and Saturday.
Review of the physician orders revealed no order for Enoxaparin. An order with a start date of 11/01/23 for
Warfarin five mg one and half tablets every Monday, Wednesday and Friday. An order 11/02/23 on for
Warfarin five mg in the evening of Tuesday, Thursday, Saturday and Sunday.
Review of the November 2023 Medication Administration Record (MAR) revealed no documentation
Warfarin had been given. Additionally, there was no documentation regarding the administration of
Enoxaparin.
Interview on 12/05/23 at 1:51 P.M. with the Director of Nursing (DON) revealed it was reported to her
Resident #10 had been upset with staff regarding his medications. The DON stated upon review it was
discovered Resident #10's medications had not been ordered properly upon his admission. The DON
verified Resident #10's admission medications were not initiated upon as prescribed, and he did not receive
Enoxaparin Sodium or Warfarin as ordered.
Review of medication information from Medscape (at
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
365426
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365426
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/05/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Arbors West
375 West Main Street
West Jefferson, OH 43162
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
https://reference.medscape.com/drug/lovenox-enoxaparin-342174 and
https://reference.medscape.com/drug/coumadin-jantoven-warfarin-342182) revealed Enoxaparin
(Leovenox) is an injectable anticoagulant and can be used to treat or prevent deep vein thrombosis,
unstable angina (chest paint) or acute coronary syndrome. Warfarin (Coumadin) is an oral anticoagulant
and can be used to treat conditions such as venous thrombosis, stroke, cardiac valve replacement,
post-myocardial infarction. According the Medscape anticoagulants should not be increased or stopped
unless directed by a doctor.
This deficiency represents non-compliance investigated under Complaint Number OH00148132.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365426
If continuation sheet
Page 2 of 2